Akèy › Kadyomiopati
Etid klinik pou Kadyomiopati ap rekrite nan Etazini
44 etid pou Kadyomiopati ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY10 etid
- Boston, MA9 etid
- Rochester, MN8 etid
- Washington, DC8 etid
- San Diego, CA7 etid
- Baltimore, MD7 etid
- Indianapolis, IN6 etid
- St. Louis, MO6 etid
- Dallas, TX6 etid
- Philadelphia, PA6 etid
- Charleston, SC6 etid
- Richmond, VA6 etid
- Mountain View, CA5 etid
- Detroit, MI5 etid
- Nashville, TN5 etid
- Houston, TX5 etid
- Chicago, IL5 etid
- Durham, NC5 etid
- Portland, OR4 etid
- Atlanta, GA4 etid
- Cleveland, OH4 etid
- Arlington, VA4 etid
- Seattle, WA4 etid
- Rochester, NY3 etid
- Ann Arbor, MI3 etid
- Los Angeles, CA3 etid
- Pittsburgh, PA3 etid
- New Haven, CT3 etid
- Salt Lake City, UT3 etid
- Columbus, OH3 etid
- Aurora, CO3 etid
- Jacksonville, FL3 etid
- Kansas City, MO3 etid
Pa eta
- Arizona5 etid
- Colorado4 etid
- Connecticut4 etid
- Distrik Columbia7 etid
- Florid8 etid
- Georgia5 etid
- Illinois5 etid
- Indiana6 etid
- Kalifòni14 etid
- Kansas3 etid
- Maryland9 etid
- Massachusetts9 etid
- Michigan7 etid
- Minnesota8 etid
- Missouri9 etid
- New York14 etid
- North Carolina7 etid
- Ohio6 etid
- Oregon4 etid
- Pennsylvania6 etid
- South Carolina6 etid
- Tennessee6 etid
- Texas9 etid
- Utah3 etid
- Virginia7 etid
- Washington4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
Ap rekriteFaz 1
Laj 12 a 50 · Tout sèks · Mizajou Sep 28, 2026 · NCT05302271Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 1 a 100 · Tout sèks · Mizajou Sep 22, 2026 · NCT01143454ATR 1072 in Participants With PRKAG2 Syndrome
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 18, 2026 · NCT07738107TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 16, 2026 · NCT07052903Targeted Ablation to Isolate Scar Channels Causing Ventricular Tachycardia
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07814079DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07358078Early Screening and Treatment of Heart Complication in Sickle Cell Disease
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07023666Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 a 100 · Tout sèks · Mizajou Sep 8, 2026 · NCT03581318Clinical Course Of Disease In Participants With FA-CM
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06865482Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Ap rekriteFaz 2
Laj 6 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07721025Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
Ap rekriteFaz 1
Laj 8 a 18 · Gason · Mizajou Aug 24, 2026 · NCT07172971Impella Reverse Remodeling in End-Stage Heart Failure
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT06800716Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Ap rekriteFaz 2
Laj 0 a 16 · Tout sèks · Mizajou Aug 10, 2026 · NCT06080074Cardiovascular Multimodality Imaging Study
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06610019TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT05507879Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Jul 29, 2026 · NCT07695701Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 12 a 50 · Tout sèks · Mizajou Jul 29, 2026 · NCT02316314Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 28, 2026 · NCT07674758Danon Disease Natural History Study
Ap rekriteEtid obsèvasyon
Laj 8 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT06214507The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT05034432A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jun 30, 2026 · NCT07137338Pediatric Cardiomyopathy Mutation Analysis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jun 22, 2026 · NCT02432092Psychosocial Support for Patients With Takotsubo Syndrome
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT05977049Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06209359Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.